The global Nicotinamide (Vitamin B3) market saw a strong recovery in August 2025 after months of decline, driven by strategic inventory reassessment and renewed demand across pharmaceuticals, nutraceuticals, and personal care sectors. Oversupply earlier in the year had led to reduced offtake, but buyers have returned with fresh procurement strategies aligned with new production cycles. Seasonal anticipation and awareness campaigns by institutions like NIH have further supported demand. European R&D activity, especially in Germany, has also contributed to market stability, pointing to a firm and steady outlook ahead.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
